Next Article in Journal
Combined PI3K Inhibitor and Eribulin Enhances Anti-Tumor Activity in Preclinical Models of Paclitaxel-Resistant, PIK3CA-Mutated Endometrial Cancer
Previous Article in Journal
Current and Emerging Strategies to Treat Urothelial Carcinoma
 
 
Review

Article Versions Notes

Cancers 2023, 15(19), 4888; https://doi.org/10.3390/cancers15194888
Action Date Notes Link
article xml file uploaded 8 October 2023 14:40 CEST Original file -
article xml uploaded. 8 October 2023 14:40 CEST Update https://www.mdpi.com/2072-6694/15/19/4888/xml
article pdf uploaded. 8 October 2023 14:40 CEST Version of Record https://www.mdpi.com/2072-6694/15/19/4888/pdf
article supplementary file uploaded. 8 October 2023 14:40 CEST - https://www.mdpi.com/2072-6694/15/19/4888#supplementary
article html file updated 8 October 2023 14:41 CEST Original file https://www.mdpi.com/2072-6694/15/19/4888/html
Back to TopTop